Results 71 to 80 of about 5,090,795 (152)

New Zealand regions, 1986-2001: Population structures [PDF]

open access: yes, 2005
The age structure of a region’s population affects many areas of social and economic development across all sectors, including employment, housing, welfare, health and education.
Lindop, J.   +3 more
core  

Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors

open access: yesPharmaceutics
Background/Objectives: Palbociclib, an oral CDK 4/6 inhibitor, was evaluated in a Pediatric Brain Tumor Consortium (PBTC) phase 1 (NCT02255461; PBTC-042) study to treat children and young adults with recurrent, progressive, or refractory brain tumors ...
John C. Panetta   +3 more
doaj   +1 more source

Rutin and Physalis peruviana Extract: Population Pharmacokinetics in New Zealand Rabbits

open access: yes
Background/Objectives: An extract of calyces from Physalis peruviana with hypoglycemic activity is being considered as a potential herbal medicine. Preclinical pharmacokinetics (PK) studies of the extract in rats, focusing on plasma concentrations of its
Diana Marcela Aragón   +4 more
core   +1 more source

A Trial of Systematic Education of Computer Sciences to Improve Comprehension of Pharmacokinetics [PDF]

open access: yes, 2008
To improve students’comprehension of pharmacokinetics, we tried a systematic education of computer sciences with the aid of e-learning system. We reconstructed the curriculum to incorporate practical course using Microsoft Excel from first-year students,
西田, 孝洋   +5 more
core  

Pharmacokinetics and population pharmacokinetics in pediatric oncology

open access: yes, 2019
Pharmacokinetic research has become increasingly important in pediatric oncology as it can have direct clinical implications and is a crucial component in individualized medicine.
Zwaan, C. Michel   +3 more
core   +1 more source

Population Pharmacokinetic Modeling and Exposure‐Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies

open access: yesCPT: Pharmacometrics & Systems Pharmacology
Nemtabrutinib is a Bruton's tyrosine kinase (BTK) inhibitor under clinical investigation in patients with hematologic malignancies, including chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL).
Chiara C. Kemal   +3 more
doaj   +1 more source

Population Pharmacokinetic and Exposure‐Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma

open access: yesCPT: Pharmacometrics & Systems Pharmacology
Efficacy and safety of ibrutinib 560 mg once daily or placebo combined with bendamustine and rituximab (BR) were assessed in patients with mantle cell lymphoma in a randomized phase 3 study (SHINE).
Per Olsson Gisleskog   +5 more
doaj   +1 more source

Population trends, convictions and imprisonment: Demographic divergence, dichotomy and diversity [PDF]

open access: yes, 2006
The links between population patterns and trends, and policy and planning for the justice system is important. The trends in the number of convictions and imprisonments by regional councils are investigated for the period 1986 to 2001. This does not just
Pool, Ian, Baxendine, Sandra
core  

The New Zealand population: A synopsis of trends and projections 1991 - 2016 [PDF]

open access: yes, 2005
Although there are many excellent documents and online resources available on New Zealand population trends, it is useful to highlight some key trends in one short document. This paper provides a synopsis of trends with respect to population size and age
Hillcoat-Nallétamby, Sarah   +4 more
core  

Population Pharmacokinetics and Dosing Optimization of Norvancomycin for Chinese Patients with Community-Acquired Pneumonia [PDF]

open access: yes
Yaqian Li,1 Xiaodan Jiao,2 Guozhu Sun,3 Fuxu Wang,4 Xikun Wu,1 Weichong Dong,1 Wenpeng Lu,3 Zhiyong Zhang,1 Yadong Yuan,2 Zhiqing Zhang1 1Department of Pharmacy, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, People’s Republic of ...
Li Y   +8 more
core  

Home - About - Disclaimer - Privacy